LUNDBECK INSTITUTE
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98553575
- Registration number
- 7814488
- Mark type
- Word mark
- Filed
- 16 May 2024
- Published for opposition
- 15 Apr 2025
- Registered
- 03 Jun 2025
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances, for the treatment of disorders and diseases acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood swings, psychosis, anxiety, apathy, epilepsy; pharmaceutical preparations and substances for the prevention and treatment of Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinsons disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and suffering, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourettes syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, drowsiness, nausea, migraine, pain, alcoholism and addiction; diagnostic preparations, substances, reagents and agents for medical purposes
- Class 009 — Scientific and electric apparatus: Downloadable electronic publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, disease awareness, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine, medicine, pharmaceuticals, disorders, diseases, clinical or medical treatment and prevention; downloadable and recorded computer software for creating searchable databases of medical and pharmaceutical information, education, namely, educational software featuring instruction in medicine and sales activities, namely, software for others for use in sales management; downloadable and recorded computer software for analyzing medical and pharmaceutical information and disease awareness; software, namely, downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for analyzing medical and pharmaceutical information; apparatus and instruments, namely, downloadable computer software for analyzing medical and pharmaceutical information in the field of research and development, science, clinical studies, medical clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; electronic downloadable publications, namely, magazines, journals, teaching and educational materials in the field of pharmaceutical research and development, science, medical clinical studies, pharmaceutical tests and trials, diagnostic medicine related to clinical or medical treatment and prevention; downloadable and recorded application software for mobile devices in the nature of mobile phones, namely, software for the assessment of cognitive functions; downloadable computer software for the assessment of cognitive functions; downloadable and recorded computer software for use in diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, migraine, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine
- Class 016 — Paper goods and printed matter: Printed publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, records in the nature of informational sheets, educational and training materials for research and development, science, clinical studies, tests and trials, diagnostics, medicine, drugs, disorders, diseases, treatment and prevention
- Class 038 — Telecommunications services: Arranging and conducting an online forum in the field of pharmaceuticals, disease awareness and treatments; providing online chat rooms and electronic bulletin boards for transmission of messages among computer users in the field of pharmaceuticals, disease awareness and treatments
- Class 041 — Education and entertainment services: Educational services, namely, conducting seminars in the field of pharmaceuticals and disease awareness; providing of training in the nature of conferences, courses, seminars and workshops in the field of pharmaceuticals and disease awareness; arranging and conducting seminars, conferences, symposiums, training workshops and courses in the field of pharmaceuticals and disease awareness; educational training services in the nature of conferences, courses, seminars and workshops in the fields of pharmaceutical research and development, medical clinical studies, pharmaceutical tests and trials and diagnostic medicine related to the treatment and prevention of diseases and disorders; providing the aforementioned services electronically in the nature of online and non-downloadable, on-line, via cable and Internet and other electronic media, namely, podcasts, audio and visual media; arranging and conducting expert forums, namely, on-line training programs in the field of pharmaceuticals; providing online, non- downloadable publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of pharmaceutical research and development, science, medical clinical studies in the field of pharmaceutical tests and trials, diagnostic medicine, pharmaceuticals, disorders, disease awareness, treatment and prevention related to the assessment of cognitive functions; providing educational assessment services in the field of cognitive functions through on-line non- downloadable screening tools
- Class 042 — Scientific and technological services: Pharmaceutical research and development; scientific and technological services, namely, scientific testing and research related to medical disorders, medical diseases and medical prevention; scientific and technological services, namely, scientific testing and research related to the central nervous system and central nervous system related disorders, pharmaceuticals and disease awareness; medical and clinical research, namely, pharmaceutical clinical research and conducting clinical trials for others in the field of pharmaceuticals; diagnostic research and tests, namely, providing diagnostic services for others for scientific research purposes in the field of pharmaceutical research
Owner
- H. Lundbeck A/S, Valby, DK
- H. Lundbeck A/S, Valby, DK
- H. Lundbeck A/S, Valby, DK
Prior registrations
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Dec 2024 — NON-FINAL ACTION E-MAILED
- 04 Dec 2024 — NON-FINAL ACTION WRITTEN
- 02 Dec 2024 — ASSIGNED TO EXAMINER
- 18 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 May 2024 — NEW APPLICATION ENTERED